Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Denise Damek

Concepts (197)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
21
2022
966
2.000
Why?
Glioblastoma
11
2019
250
1.140
Why?
Meningeal Neoplasms
6
2022
86
1.090
Why?
Astrocytoma
5
2014
106
1.030
Why?
Meningioma
4
2022
76
0.590
Why?
Neoplasm Recurrence, Local
9
2022
850
0.520
Why?
Chemoradiotherapy
5
2015
187
0.490
Why?
Meningeal Carcinomatosis
2
2014
8
0.450
Why?
Dacarbazine
8
2016
99
0.430
Why?
Radiotherapy, Intensity-Modulated
4
2015
124
0.410
Why?
Angiogenesis Inhibitors
2
2014
213
0.390
Why?
Glioma
4
2020
285
0.390
Why?
Proto-Oncogene Proteins B-raf
1
2012
191
0.360
Why?
Antineoplastic Agents, Alkylating
5
2016
68
0.350
Why?
Neuroaspergillosis
1
2008
2
0.320
Why?
Quadriplegia
1
2008
12
0.320
Why?
Aspergillus
1
2008
16
0.320
Why?
Brain Abscess
1
2008
10
0.310
Why?
Spinal Cord Diseases
1
2008
38
0.310
Why?
Neck
1
2008
85
0.300
Why?
Brain Diseases
1
2009
124
0.300
Why?
Posture
1
2008
152
0.290
Why?
Bevacizumab
5
2020
114
0.290
Why?
Mutation
3
2022
3338
0.270
Why?
Range of Motion, Articular
1
2008
350
0.270
Why?
Middle Aged
24
2020
26605
0.220
Why?
Antibodies, Monoclonal
2
2009
1257
0.220
Why?
Carcinoma, Non-Small-Cell Lung
2
2014
959
0.200
Why?
Seizures
2
2017
337
0.180
Why?
Flucytosine
1
2020
9
0.180
Why?
Cytosine Deaminase
1
2020
14
0.180
Why?
Radiosurgery
3
2010
299
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1356
0.180
Why?
Lymphoma
3
2008
176
0.180
Why?
Multiple Sclerosis
2
2012
372
0.170
Why?
Quinazolines
3
2014
240
0.170
Why?
Antineoplastic Agents
3
2020
1875
0.160
Why?
Central Nervous System Neoplasms
3
2008
125
0.160
Why?
Female
25
2020
59325
0.160
Why?
Neurologic Examination
1
2019
113
0.160
Why?
Brain
2
2009
2355
0.150
Why?
Emergency Service, Hospital
1
2009
1815
0.150
Why?
Adenocarcinoma
1
2004
787
0.150
Why?
Humans
33
2022
114043
0.150
Why?
Aged
18
2020
18969
0.150
Why?
Lung Neoplasms
2
2014
2159
0.150
Why?
Antibodies, Monoclonal, Humanized
2
2014
660
0.140
Why?
Isocitrate Dehydrogenase
2
2020
38
0.140
Why?
Magnetic Resonance Imaging
7
2016
3039
0.140
Why?
Brain Edema
2
2009
59
0.140
Why?
Magnetic Field Therapy
1
2016
2
0.140
Why?
Prognosis
5
2015
3315
0.140
Why?
Neurosurgical Procedures
1
2017
150
0.130
Why?
Survival Rate
4
2015
1638
0.130
Why?
Neoplasms
1
2009
2086
0.130
Why?
Male
23
2020
55396
0.120
Why?
Radiotherapy, Adjuvant
2
2014
182
0.120
Why?
Oligodendroglioma
1
2014
15
0.120
Why?
Adult
17
2017
30375
0.120
Why?
Severity of Illness Index
2
2019
2537
0.120
Why?
Combined Modality Therapy
5
2016
1117
0.110
Why?
Follow-Up Studies
4
2016
4392
0.110
Why?
Pregnancy Complications
1
1997
430
0.110
Why?
Immunoenzyme Techniques
1
2012
192
0.100
Why?
Chemotherapy, Adjuvant
4
2015
332
0.100
Why?
Green Fluorescent Proteins
1
2012
370
0.090
Why?
Carcinoma
1
2012
198
0.090
Why?
ErbB Receptors
1
2014
554
0.090
Why?
Polymerase Chain Reaction
1
2012
990
0.080
Why?
Paraneoplastic Syndromes, Nervous System
1
2009
9
0.080
Why?
Piperidines
1
2010
159
0.080
Why?
Autopsy
1
2009
83
0.080
Why?
Chloral Hydrate
1
2008
3
0.080
Why?
Prospective Studies
7
2015
6195
0.080
Why?
Quetiapine Fumarate
1
2008
21
0.080
Why?
Practice Guidelines as Topic
1
2016
1381
0.080
Why?
Dibenzothiazepines
1
2008
17
0.080
Why?
Tumor Suppressor Protein p53
1
2012
445
0.080
Why?
Oxycodone
1
2008
44
0.080
Why?
Delirium
1
2009
66
0.080
Why?
Drug Combinations
1
2008
286
0.070
Why?
Epstein-Barr Virus Infections
1
2008
72
0.070
Why?
Hypnotics and Sedatives
1
2008
133
0.070
Why?
Analgesics, Non-Narcotic
1
2008
117
0.070
Why?
Postoperative Complications
1
2017
2122
0.070
Why?
Diagnostic Imaging
1
2009
278
0.070
Why?
Antipsychotic Agents
1
2008
183
0.070
Why?
Immune Tolerance
1
2008
321
0.070
Why?
Tumor Burden
3
2012
258
0.060
Why?
Acetaminophen
1
2008
241
0.060
Why?
Young Adult
4
2017
10444
0.060
Why?
Maximum Tolerated Dose
3
2010
183
0.060
Why?
Occipital Lobe
1
2004
23
0.060
Why?
Diagnosis, Differential
1
2008
1331
0.060
Why?
Drug Overdose
1
2008
292
0.060
Why?
Time Factors
3
2010
6077
0.060
Why?
Radiotherapy
1
2004
175
0.060
Why?
Methotrexate
2
2008
227
0.060
Why?
Neoplasms, Neuroepithelial
1
2003
15
0.050
Why?
Neoplasm Staging
3
2015
1162
0.050
Why?
Peripheral Nervous System Neoplasms
1
2003
20
0.050
Why?
Retrospective Studies
5
2022
12521
0.050
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2022
27
0.050
Why?
Quality of Life
1
2013
2343
0.050
Why?
Adolescent
4
2017
17800
0.050
Why?
Dementia
1
2005
186
0.050
Why?
Karnofsky Performance Status
2
2013
36
0.050
Why?
Transferases
1
2022
28
0.050
Why?
Treatment Outcome
4
2020
9049
0.050
Why?
Drug Administration Schedule
3
2010
714
0.050
Why?
Lomustine
1
2020
14
0.050
Why?
Stroke
1
2009
1019
0.040
Why?
Survival Analysis
2
2020
1206
0.040
Why?
Standard of Care
1
2020
62
0.040
Why?
Radiotherapy Dosage
2
2010
243
0.040
Why?
Dexamethasone
2
2012
316
0.040
Why?
Reoperation
2
2012
513
0.040
Why?
Antimetabolites, Antineoplastic
1
1999
80
0.040
Why?
Biopsy
2
2017
1024
0.040
Why?
Lymphoma, Non-Hodgkin
1
1999
70
0.040
Why?
Aged, 80 and over
5
2010
6306
0.040
Why?
DNA Methylation
1
2022
493
0.040
Why?
Recombinant Proteins
1
2020
1228
0.040
Why?
Intraoperative Complications
1
2017
120
0.030
Why?
Disease Susceptibility
1
1997
316
0.030
Why?
Cognition Disorders
2
2014
476
0.030
Why?
Analysis of Variance
2
2014
1218
0.030
Why?
Anticonvulsants
1
2017
178
0.030
Why?
DNA
1
2022
1350
0.030
Why?
Neuropsychological Tests
2
2013
926
0.030
Why?
Acute Disease
1
1997
907
0.030
Why?
Marital Status
1
2014
41
0.030
Why?
Erlotinib Hydrochloride
1
2014
64
0.030
Why?
SEER Program
1
2014
195
0.030
Why?
Sequence Deletion
1
2014
166
0.030
Why?
Sex Factors
2
2014
1706
0.030
Why?
Exons
1
2014
301
0.030
Why?
Lymphoma, Large B-Cell, Diffuse
2
2005
97
0.030
Why?
Proportional Hazards Models
2
2010
1078
0.030
Why?
Disease Progression
1
2019
2371
0.020
Why?
Chronic Disease
1
1997
1577
0.020
Why?
Age Factors
2
2014
2885
0.020
Why?
PTEN Phosphohydrolase
1
2012
140
0.020
Why?
DNA Mutational Analysis
1
2012
373
0.020
Why?
Longitudinal Studies
1
1997
2384
0.020
Why?
Retreatment
1
2010
67
0.020
Why?
Carmustine
1
2010
47
0.020
Why?
Vincristine
1
2010
98
0.020
Why?
Case-Control Studies
1
2017
3003
0.020
Why?
Carboplatin
1
2010
135
0.020
Why?
Camptothecin
1
2010
96
0.020
Why?
Neoplasm, Residual
1
2010
104
0.020
Why?
Dose-Response Relationship, Drug
1
2014
1836
0.020
Why?
Necrosis
1
2010
209
0.020
Why?
Salvage Therapy
1
2010
127
0.020
Why?
Algorithms
1
2016
1469
0.020
Why?
Tomography Scanners, X-Ray Computed
1
2008
17
0.020
Why?
Antigens, CD20
1
2008
27
0.020
Why?
Anti-Inflammatory Agents
1
2012
445
0.020
Why?
Immunoglobulin Heavy Chains
1
2008
72
0.020
Why?
Protein Kinase Inhibitors
1
2014
784
0.020
Why?
CD3 Complex
1
2008
92
0.020
Why?
Administration, Oral
1
2010
725
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2008
82
0.020
Why?
Risk Assessment
1
2017
2958
0.020
Why?
Linear Models
1
2010
768
0.020
Why?
Rituximab
1
2008
148
0.020
Why?
Mental Status Schedule
1
2007
33
0.020
Why?
Cross-Sectional Studies
1
1997
4402
0.020
Why?
Glucocorticoids
1
2010
526
0.020
Why?
Cognition
1
2013
990
0.020
Why?
Pregnancy
1
1997
5499
0.020
Why?
Dementia, Vascular
1
2005
16
0.020
Why?
Optic Nerve
1
2005
65
0.010
Why?
Immunosuppressive Agents
1
2008
641
0.010
Why?
Fatal Outcome
1
2005
281
0.010
Why?
Lymphoma, B-Cell
1
2005
87
0.010
Why?
Genetic Predisposition to Disease
1
2012
2090
0.010
Why?
Astrocytes
1
2005
159
0.010
Why?
Child
1
2022
18400
0.010
Why?
Microglia
1
2005
198
0.010
Why?
United States
2
2014
12137
0.010
Why?
Spinal Cord
1
2005
344
0.010
Why?
Cohort Studies
1
2010
4883
0.010
Why?
Colorado
1
2010
4090
0.010
Why?
Actuarial Analysis
1
1999
21
0.010
Why?
Remission Induction
1
1999
233
0.010
Why?
Databases as Topic
1
1998
63
0.010
Why?
Animals
1
1997
31565
0.010
Why?
Forecasting
1
1998
331
0.010
Why?
Activities of Daily Living
1
1998
348
0.010
Why?
Multivariate Analysis
1
1998
1422
0.010
Why?
Hospitals
1
1998
581
0.010
Why?
Logistic Models
1
1998
1829
0.010
Why?
Registries
1
1998
1764
0.010
Why?
Surveys and Questionnaires
1
1999
4595
0.000
Why?
Risk Factors
1
1998
8614
0.000
Why?
Damek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)